Last, a “full length” form of PYK2 (PTK2B), including alternative exon 23, is enriched in BCR-ABL1 expressing CD34+ cells (by transduction as well as in CP CML primary cells). This evidence concerns the gene PTK2B and chronic myelogenous leukemia, BCR-ABL1 positive.